Oppenheimer Asset Management Inc. purchased a new position in Henry Schein, Inc. (NASDAQ:HSIC) during the first quarter, Holdings Channel reports. The fund purchased 11,163 shares of the company’s stock, valued at approximately $1,898,000.
A number of other institutional investors have also recently made changes to their positions in the company. Vanguard Group Inc. raised its stake in Henry Schein by 1.7% in the first quarter. Vanguard Group Inc. now owns 7,849,455 shares of the company’s stock valued at $1,334,173,000 after buying an additional 127,660 shares in the last quarter. BlackRock Inc. increased its stake in Henry Schein by 2,999.6% in the first quarter. BlackRock Inc. now owns 5,595,279 shares of the company’s stock valued at $951,028,000 after buying an additional 5,414,761 shares during the period. Mackenzie Financial Corp increased its stake in Henry Schein by 4.7% in the first quarter. Mackenzie Financial Corp now owns 1,728,230 shares of the company’s stock valued at $293,747,000 after buying an additional 76,794 shares during the period. JPMorgan Chase & Co. increased its stake in Henry Schein by 12.4% in the first quarter. JPMorgan Chase & Co. now owns 1,515,861 shares of the company’s stock valued at $257,650,000 after buying an additional 167,213 shares during the period. Finally, Swedbank increased its stake in Henry Schein by 1.6% in the first quarter. Swedbank now owns 1,257,291 shares of the company’s stock valued at $213,702,000 after buying an additional 19,885 shares during the period. Institutional investors own 90.74% of the company’s stock.
Shares of Henry Schein, Inc. (HSIC) opened at 182.87 on Wednesday. Henry Schein, Inc. has a 12-month low of $146.23 and a 12-month high of $186.99. The stock’s 50 day moving average is $180.88 and its 200 day moving average is $168.29. The firm has a market cap of $14.51 billion, a price-to-earnings ratio of 27.79 and a beta of 1.10.
Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings data on Tuesday, May 9th. The company reported $1.76 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.65 by $0.11. The company had revenue of $2.92 billion during the quarter, compared to analysts’ expectations of $2.83 billion. Henry Schein had a net margin of 4.53% and a return on equity of 19.74%. Henry Schein’s revenue for the quarter was up 7.7% compared to the same quarter last year. During the same period in the prior year, the company posted $1.41 earnings per share. Equities analysts expect that Henry Schein, Inc. will post $7.28 earnings per share for the current year.
A number of brokerages have recently weighed in on HSIC. Zacks Investment Research upgraded Henry Schein from a “hold” rating to a “buy” rating and set a $206.00 price target on the stock in a research note on Thursday, June 1st. Piper Jaffray Companies assumed coverage on Henry Schein in a report on Monday, June 12th. They issued a “neutral” rating and a $200.00 target price for the company. Barrington Research upped their target price on Henry Schein from $196.00 to $198.00 and gave the company an “outperform” rating in a report on Wednesday, May 10th. Stifel Nicolaus upped their target price on Henry Schein from $174.00 to $178.00 and gave the company a “hold” rating in a report on Wednesday, May 10th. Finally, Jefferies Group LLC reaffirmed a “hold” rating and issued a $165.00 price target on shares of Henry Schein in a research note on Tuesday, February 28th. Ten research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. The stock currently has an average rating of “Hold” and an average target price of $184.08.
In other news, EVP Gerald A. Benjamin sold 12,578 shares of Henry Schein stock in a transaction dated Thursday, May 11th. The shares were sold at an average price of $175.10, for a total value of $2,202,407.80. Following the completion of the transaction, the executive vice president now owns 44,061 shares in the company, valued at $7,715,081.10. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 1.27% of the company’s stock.
About Henry Schein
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).
This story was originally published by sleekmoney (https://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://sleekmoney.com/oppenheimer-asset-management-inc-takes-position-in-henry-schein-inc-hsic/1945962.html
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.